REGN - Financial Reports List - Regeneron Pharmaceuticals, Inc. - IntrinsicAlpha

Regeneron Pharmaceuticals, Inc. REGN

Healthcare - Biotechnology - NASDAQ - US

$ 585.315

-0.297 %

$ 62.6 B

Market Cap

14.64

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	10.33%	-20.86%	1.78%
Annual Report	FY	10-K	2024-12-31	8.27%	11.61%	-1.39%
Quarterly Report	Q3	8-K	2024-09-30	10.65%	33.02%	6.17%
Quarterly Report	Q2	8-K	2024-06-30	12.32%	47.90%	7.58%
Quarterly Report	Q1	8-K	2024-03-31	-0.54%	-11.71%	-19.88%
Quarterly Report	Q4	8-K	2023-12-31	0.58%	-3.13%	-15.16%
Annual Report	FY	10-K	2023-12-31	7.76%	-8.87%	-14.60%
Quarterly Report	Q3	8-K	2023-09-30	14.53%	-23.40%	-9.21%
Quarterly Report	Q2	8-K	2023-06-30	10.53%	13.65%	-8.42%
Quarterly Report	Q1	8-K	2023-03-31	6.64%	-15.99%	-24.78%

1